PTC Therapeutics (PTCT)
(Delayed Data from NSDQ)
$31.54 USD
-0.06 (-0.19%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $31.59 +0.05 (0.16%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
PTC Therapeutics (PTCT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$39.71 | $64.00 | $26.00 | 25.66% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for PTC Therapeutics comes to $39.71. The forecasts range from a low of $26.00 to a high of $64.00. The average price target represents an increase of 25.66% from the last closing price of $31.60.
Analyst Price Targets (14)
Broker Rating
PTC Therapeutics currently has an average brokerage recommendation (ABR) of 2.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 2.62 a month ago based on 13 recommendations.
Of the 15 recommendations deriving the current ABR, seven are Strong Buy, representing 46.67% of all recommendations. A month ago, Strong Buy represented 38.46%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 6 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 2 | 2 | 2 | 2 | 2 |
ABR | 2.40 | 2.50 | 2.62 | 2.62 | 2.62 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/4/2024 | Robert W. Baird & Co. | Joel L Beatty | Not Available | Strong Buy |
8/26/2024 | UBS | Eliana Merle | Not Available | Strong Buy |
8/9/2024 | William Blair | Sami Corwin | Strong Buy | Strong Buy |
8/9/2024 | Not Identified | Not Identified | Hold | Hold |
8/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/1/2024 | SVB Securities | Joseph P Schwartz | Hold | Hold |
7/9/2024 | Not Identified | Not Identified | Hold | Hold |
7/1/2024 | Cantor Fitzgerald & Co | Kristen Kluska | Strong Buy | Strong Buy |
6/21/2024 | Wells Fargo Securities | Tiago Fauth | Strong Buy | Strong Buy |
5/21/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
5/21/2024 | Goldman Sachs | Paul K Choi | Strong Sell | Strong Sell |
4/1/2024 | Cowen & Co. | Joseph Thome | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.40 |
ABR (Last week) | 2.50 |
# of Recs in ABR | 15 |
Average Target Price | $39.71 |
LT Growth Rate | 22.00% |
Industry | Medical - Drugs |
Industry Rank by ABR | 98 of 253 |
Current Quarter EPS Est: | -1.53 |
PTCT FAQs
PTC Therapeutics, Inc. (PTCT) currently has an average brokerage recommendation (ABR) of 2.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms.
The average price target for PTC Therapeutics, Inc. (PTCT) is $39.71. The current on short-term price targets is based on 8 reports.
The forecasts for PTC Therapeutics, Inc. (PTCT) range from a low of $26 to a high of $64. The average price target represents a increase of $25.90 from the last closing price of $31.54.
The current UPSIDE for PTC Therapeutics, Inc. (PTCT) is 25.90%
Based on short-term price targets offered by 14 analysts, the average price target for PTC Therapeutics comes to $39.71. The forecasts range from a low of $26.00 to a high of $64.00. The average price target represents an increase of 25.66% from the last closing price of $31.60.